GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹342 Cr | ₹151 Cr | ₹238 Cr | ₹177 Cr | ₹181 Cr |
What is the latest Capital Work in Progress ratio of GLAND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹342 Cr |
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹238 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹181 Cr |
How is Capital Work in Progress of GLAND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹342 Cr | 127.27 | |
| Mar2025 | ₹151 Cr | -36.71 | |
| Mar2024 | ₹238 Cr | 34.23 | |
| Mar2023 | ₹177 Cr | -1.95 | |
| Mar2022 | ₹181 Cr | - | |
Compare Capital Work in Progress of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,524.7 Cr | 5.1% | 3.5% | 57.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 5.1% |
3.5% |
57.2% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses